GlobalData on MSN23h
Eli Lilly pays $10m upfront for Organovo’s FXR agonist
Eli Lilly (Lilly) has agreed to make a $10m upfront payment for full worldwide rights to San Diego-based Organovo Holdings’ ...
Top Biotech Stocks To Follow Today – February 25th
AbbVie, Danaher, Organovo, Thermo Fisher Scientific, and Vertex Pharmaceuticals are the five Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks are shares of ...
Eli Lilly shares climb for seven consecutive sessions
Eli Lilly (NYSE:LLY) shares soar, driven by strong growth in weight-loss drugs, major investments, and bullish analyst ratings.
MT Newswires on MSN15h
Eli Lilly Plans 4 New US Manufacturing Sites With $27 Billion Investment
Eli Lilly (LLY) on Wednesday outlined a plan to invest at least $27 billion to build four new pharmaceutical manufacturing sites in the US. The pharmaceutical giant said that three of the planned ...
The Pharma Letter22h
All smiles at GRIN over radiprodil prospects
Neurodevelopmental disorders company GRIN Therapeutics, an affiliate of the Blackstone Life Sciences portfolio company ...
Truist Financial Keeps Their Buy Rating on Eli Lilly & Co (LLY)
Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today. The company’s shares ...
Eli Lilly to boost U.S. manufacturing footprint amid Trump’s tariff threats
Eli Lilly (NYSE:LLY) announced plans to more than double its investments in domestic medicine production to over $50B on ...